Announcement on Amendments to the Report on Issuing Shares and Paying Cash to Purchase Assets and Raising Supporting Funds and Related Party Transactions (Draft for Review)

Maple Medical Co., Ltd.·June 29, 2026·2 pages

✨ AI Summary

Guangzhou Medprin Regenerative Medical Technology Co., Ltd. announces amendments to its report regarding the acquisition of Guangzhou Zexin Medical Technology Co., Ltd. and other assets. The revisions address procedural matters and update financial reporting post-closing date, as per Shenzhen Stock Exchange's review.

Summary generated by AI · Always verify with source document

Full Translation

AI Translation· gemini_document

Guangzhou Medprin Regenerative Medical Technology Co., Ltd.

Announcement on Amendments to the Report on Issuing Shares and Paying Cash to Purchase Assets and Raising Supporting Funds and Related Party Transactions (Draft for Review)

The Company and all members of the Board of Directors guarantee the truthfulness, accuracy, and completeness of the information disclosed, and that there are no false records, misleading statements, or material omissions.

Guangzhou Medprin Regenerative Medical Technology Co., Ltd. (hereinafter referred to as the "Listed Company" or the "Company") intends to acquire 100% equity of Guangzhou Yijie Medical Technology Co., Ltd. (hereinafter referred to as the "Target Company" or "Yijie Medical") held by Guangzhou Zexin Medical Technology Co., Ltd., Guangzhou Yichuang Investment Partnership (Limited Partnership), and 10 other counterparties by issuing shares and paying cash, and to raise supporting funds (hereinafter referred to as the "Transaction").

Free accounts get 10 full releases per month. Pro subscribers get unlimited access.